galectin.jpg
Autoimmune Disease Patent Granted to Galectin Therapeutics
June 06, 2017 08:30 ET | Galectin Therapeutics
NORCROSS, Ga., June 06, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the Company has...
Entia Biosciences, Inc. (OTCQB: ERGO) Receives Notification of the Grant of European Patent it has Exclusively Licensed for Identifying the Ergothioneine Transporter and its Therapeutic Uses
November 02, 2016 15:20 ET | Entia Biosciences, Inc.
PORTLAND, Ore., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) has been informed that the European Patent Office has granted European Patent Number 1 761 784 with the title...
CMS Five-Star Quality Rating System Identifies Satellite Healthcare as Leading 10 Largest Dialysis Providers in Percentage of Top-Rated Dialysis Centers
October 27, 2016 15:31 ET | Satellite Healthcare
SAN JOSE, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare today announced that it leads the industry with the highest percentage of top-rated dialysis centers among the 10 largest...
Entia Biosciences, Inc. (OTCQB: ERGO) to Present Results of Chronic Kidney Disease Medical Food Clinical Study at American Society of Nephrology / Kidney Week 2016 Annual Meeting
October 06, 2016 12:52 ET | Entia Biosciences, Inc.
PORTLAND, Ore., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) was informed by the American Society of Nephrology (“ASN”) that its submission of “late breaking clinical...
Preliminary clinical results for Entia Biosciences, Inc.’s new, proprietary ErgoD2® medical food show an average increase in kidney filtration rate of approximately 10% for over 75% of test subjects, after only three months
September 26, 2016 08:30 ET | Entia Biosciences, Inc.
PORTLAND, Ore., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) Founder and Chief Science and Technology Officer, Dr. Marvin Hausman, has reported better-than-expected...
Satellite Healthcare Partners with American Kidney Fund to Support Clinical Research
August 15, 2016 09:00 ET | Satellite Healthcare
SAN JOSE, Calif., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce that it has joined forces with the American Kidney...
Satellite Healthcare Congratulates 2016 Coplon Grant Recipients
August 11, 2016 09:00 ET | Satellite Healthcare
SAN JOSE, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce the recipients of the 2016 Norman S. Coplon...
UPDATE -- Entia Biosciences, Inc. Begins Clinical Study of Proprietary ErgoD2® Medical Food Product to Demonstrate Improved Health for the More Than 25 Million Chronic Kidney Disease Sufferers in the U.S.
December 21, 2015 15:12 ET | Entia Biosciences, Inc.
PORTLAND, Ore., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) Founder and Chief Science and Technology Officer, Dr. Marvin Hausman, has reported greater-than-expected...
Entia Biosciences, Inc. Begins Clinical Study of Proprietary ErgoD2® Medical Food Product to Demonstrate Improved Health for the More Than 25 Million Chronic Kidney Disease Sufferers in the U.S.
December 21, 2015 08:50 ET | Entia Biosciences, Inc.
PORTLAND, Ore., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) Founder and Chief Science and Technology Officer, Dr. Marvin Hausman, has reported greater-than-expected...
North Shore-LIJ Receives $2.5 Million Federal Grant to Expand Kidney Disease Program
May 27, 2014 17:08 ET | North Shore Long Island Jewish Health System
MANHASSET, N.Y. and GREAT NECK, N.Y., May 27, 2014 (GLOBE NEWSWIRE) -- The US Centers for Medicare & Medicaid Services' (CMS) Center for Innovation has awarded a $2.5 million grant that will enable...